# BPGM shapes NFAT5-driven cellular responses

**Authors:** Kameliya Roegner, Vera A. Kulow, Ralf Mrowka, Kristina Engel, Bayram Edemir, Mumtaz Kasim, Cem Erdogan, Laetitia Malotka, Michael Fähling, Robert Labes

PMC · DOI: 10.1007/s00018-026-06143-y · 2026-02-25

## TL;DR

This study shows that the enzyme BPGM helps cells respond to high salt conditions by working with the NFAT5 protein to control gene activity.

## Contribution

The study identifies BPGM as a new metabolic effector of NFAT5 in osmotic stress adaptation.

## Key findings

- BPGM is a transcriptional target of NFAT5 under hypertonic conditions.
- BPGM and NFAT5 regulate overlapping sets of genes linked to chromatin structure.
- BPGM and NFAT5 influence HIF-1α expression, connecting osmotic and hypoxic stress responses.

## Abstract

Osmotic stress represents a major challenge to cells, particularly in the kidney, where tonicity gradients are both physiologically relevant and pathologically altered. The transcription factor nuclear factor of activated T cells 5 (NFAT5) is a key regulator of the osmoadaptive response, yet its downstream metabolic effectors remain incompletely understood. In this study, we identify the glycolytic side-branch enzyme 2,3-bisphosphoglycerate mutase (BPGM) as a transcriptional NFAT5 target that is induced under hypertonic conditions. RNA-seq analysis revealed that Bpgm knockdown significantly alters gene expression under osmotic stress (450 mOsmol/kg), with substantial overlap between BPGM- and NFAT5-responsive transcriptional programs. Bpgm depletion impairs the induction of canonical NFAT5 target genes, suggesting a functional interplay between metabolic and transcriptional adaptation. Promoter enrichment analysis showed that genes regulated by both NFAT5 and BPGM under hypertonic conditions are associated with CpG islands and GC-rich elements, supporting a link to chromatin structure and transcriptional accessibility. Consistently, we show that HIF-1α expression is regulated downstream of NFAT5 and BPGM, indicating a hierarchical organization of osmotic and hypoxic stress responses. We propose that BPGM facilitates NFAT5 function through metabolic-epigenetic coupling, acting as an amplifier of protective gene expression. Notably, this axis is active in BPGM-expressing cells such as those of the distal convoluted tubule. Thus, our findings establish BPGM as a critical node in the osmoadaptive gene regulatory network and highlight how cell type-specific metabolic profiles influence the transcriptional response to hypertonic stress.

The online version contains supplementary material available at 10.1007/s00018-026-06143-y.

## Linked entities

- **Genes:** BPGM (bisphosphoglycerate mutase) [NCBI Gene 669], NFAT5 (nuclear factor of activated T cells 5) [NCBI Gene 10725], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091]
- **Proteins:** NFAT5 (nuclear factor of activated T cells 5), BPGM (bisphosphoglycerate mutase), HIF1A (hypoxia inducible factor 1 subunit alpha)

## Full-text entities

- **Genes:** Dct (dopachrome tautomerase) [NCBI Gene 13190] {aka DT, TRP-2, TRP2, Tyrp-2, Tyrp2, slaty}, Calb1 (calbindin 1) [NCBI Gene 12307] {aka Brain-2, CB, Calb, Calb-1}, BPGM (bisphosphoglycerate mutase) [NCBI Gene 669] {aka DPGM, ECYT8}, Hmox1 (heme oxygenase 1) [NCBI Gene 15368] {aka D8Wsu38e, HO-1, HO1, Hemox, Hmox, Hsp32}, Aqp2 (aquaporin 2) [NCBI Gene 11827] {aka AQP-CD, WCH-CD, cph, jpk}, Wsb1 (WD repeat and SOCS box-containing 1) [NCBI Gene 78889] {aka 1110056B13Rik, 2700038M07Rik}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Nfat5 (nuclear factor of activated T cells 5) [NCBI Gene 54446] {aka B130038B15Rik, CAG-8, CAG80, NFATL1, OREBP, TonEBP}, Egln3 (egl-9 family hypoxia-inducible factor 3) [NCBI Gene 112407] {aka 2610021G09Rik, Hif-p4h-3, Phd3, SM-20}, Slc5a2 (solute carrier family 5 (sodium/glucose cotransporter), member 2) [NCBI Gene 246787] {aka Sglt2}, Akr1b1 (aldo-keto reductase family 1 member B) [NCBI Gene 11677] {aka ALR2, AR, Ahr-1, Ahr1, Akr1b3, Aldor1}, Hk2 (hexokinase 2) [NCBI Gene 15277] {aka HKII}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, Tubb2b (tubulin, beta 2B class IIB) [NCBI Gene 73710] {aka 2410129E14Rik, brdp}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Cdh16 (cadherin 16) [NCBI Gene 12556], Bpgm (2,3-bisphosphoglycerate mutase) [NCBI Gene 12183], Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Aldoc (aldolase C, fructose-bisphosphate) [NCBI Gene 11676] {aka Aldo3, Scrg2}, Actr6 (ARP6 actin-related protein 6) [NCBI Gene 67019] {aka 2010200J04Rik, Arp6, ArpX, CDA12}, Fscn1 (fascin actin-bundling protein 1) [NCBI Gene 14086] {aka Fan1, fascin-1}, Lrp2 (low density lipoprotein receptor-related protein 2) [NCBI Gene 14725] {aka D230004K18Rik, Gp330, Megalin, b2b1625.2Clo}, Mul1 (mitochondrial ubiquitin ligase activator of NFKB 1) [NCBI Gene 68350] {aka 0610009K11Rik, Gide, Tnrip-1}, Daglb (diacylglycerol lipase, beta) [NCBI Gene 231871] {aka E330036I19Rik}, Ino80 (INO80 complex subunit) [NCBI Gene 68142] {aka 2310079N15Rik, 4632409L19Rik, Inoc1}, NFAT5 (nuclear factor of activated T cells 5) [NCBI Gene 10725] {aka NF-AT5, NFATL1, NFATZ, OREBP, TONEBP}, Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}
- **Diseases:** cancer (MESH:D009369), diabetes mellitus (MESH:D003920), CKD (MESH:D051436), inflammation (MESH:D007249), hyperglycemia (MESH:D006943), Fibrosis (MESH:D005355), glucosuria (MESH:D006030), hypoxia (MESH:D000860), hypoxic (MESH:D002534), AKI (MESH:D058186), dehydration (MESH:D003681), ketoacidosis (MESH:D007662), kidney disease (MESH:D007674), organ damage (MESH:D000092124)
- **Chemicals:** polyol (MESH:C024617), ethylene glycol (MESH:D019855), lactate (MESH:D019344), nitrogen (MESH:D009584), EDTA (MESH:D004492), Triton X-100 (MESH:D017830), polyacrylamide (MESH:C016679), TCA (MESH:D014233), streptomycin (MESH:D013307), paraffin (MESH:D010232), 2-HG (MESH:C019417), pyruvate (MESH:D019289), NaCl (MESH:D012965), mannose (MESH:D008358), Trypan blue (MESH:D014343), O2 (MESH:D010100), dithiothreitol (MESH:D004229), 2,3-bisphosphoglycerate (MESH:D019794), SDS (MESH:D012967), water (MESH:D014867), acetyl-CoA (MESH:D000105), 3-phosphoglycerate (MESH:C005156), S-adenosylmethionine (MESH:D012436), urea (MESH:D014508), DharmaFECT 1 (-), penicillin (MESH:D010406), glycerol (MESH:D005990), sodium (MESH:D012964), PBS (MESH:D007854), TBS-T (MESH:C027647), DAPI (MESH:C007293), Glucose (MESH:D005947), calcium (MESH:D002118), ROS (MESH:D017382), L-glutamine (MESH:D005973), SYBR Green (MESH:C098022), CO2 (MESH:D002245), paraformaldehyde (MESH:C003043), lipid (MESH:D008055), sucrose (MESH:D013395)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** MEFs — Mus musculus (Mouse), Finite cell line (CVCL_9115), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), MEF — Mus musculus (Mouse), Transformed cell line (CVCL_4240)

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960884/full.md

---
Source: https://tomesphere.com/paper/PMC12960884